Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Vanderbilt-led Trial Tests Whether Deep Brain Stimulations Slows Parkinson's Progression


 

A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson's disease in early-stage patients.

A grant from the Parkinson's Disease Foundation and the American Parkinson's Disease Association supporting the Disease Modification in Early Parkinson's Disease Consortium has been matched by Phyllis, Tony and Elizabeth Heard.

The trial has also received planning grant support from The Michael J. Fox Foundation for Parkinson's Research.

Mallory Hacker, Ph.D., assistant professor of Neurology, serves as executive director of the DBS in Early Stage Parkinson's Disease Study Group, which includes VUMC and 17 other U.S. medical centers.

The group is preparing to launch a Phase 3 study that has been approved by the U.S. Food and Drug Administration. Currently, DBS is approved to help control symptoms in patients with mid-stage to advanced-stage disease. The study could potentially provide the evidence required by the FDA to change the labeling for the medical device used in DBS to include early-stage Parkinson's disease. Currently, there is no therapy that is proven to stop, reverse or even slow the progression of Parkinson's disease.

"Our team's overarching goal is to determine if very early DBS will dramatically slow the progression of Parkinson's disease," said David Charles, M.D., chief medical officer of the Vanderbilt Neuroscience Institute. "If that were proven true, it would be a landmark achievement in the battle against this devastating disease."

The FDA approved the multicenter trial after VUMC researchers published results of a study in 2012 of 30 people with early-stage Parkinson's who were receiving DBS plus optimal drug therapy (ODT) or ODT alone.

Last year, the VUMC team published an updated report of the patients enrolled in that trial. They concluded that DBS in early-stage Parkinson's may reduce the risk of clinically important worsening by 50 to 80 percent after two years.

 
Share:

Related Articles:


Recent Articles

Physician Spotlight: Manny Sethi, MD: Leading by Example

Orthopaedic surgeon and community health advocate Manny Sethi, MD, is piloting a new model of healthcare for Tennesseans

Read More

Local Seniors Look to Exercise More, Eat Better in 2019

According to a new survey, Nashville seniors are ready to make the lifestyle changes necessary to improve health, increase mobility and reduce chronic pain.

Read More

Resolve to Address Obesity

Obesity and its comorbid conditions impact both lifespan and quality of life. However, not all obesity is created equal. Resolve to take simple steps help identify those most at risk for diabetes, cardiovascular disease and other complications and intervene.

Read More

Clover Health Flu Shot Monitor Finds Only 61% of Nashville Seniors Have Been Immunized This Season

With flu shot rates increasing only 20% over the past month, too many older Middle Tennessee residents remain unvaccinated going into the height of flu season

Read More

Jacobs Out at Acadia

Veteran healthcare CEO Joey Jacobs is out at Acadia Healthcare following a Sunday board meeting that ousted the behavioral health giant's well-known leader.

Read More

Moving beyond Wellness to Well-Being

Increasingly, healthcare providers are expanding their focus beyond physical wellness to take a more holistic view of well-being.

Read More

Seasonal Affective Disorder: The Recurring Winter Blues Storm

In the United States, 10 to 20 percent of people have a form of the winter blues, and about half a million people suffer from winter Seasonal Affective Disorder or SAD.

Read More

Competition Levels Drop in Health Insurance Markets across 25 States

Read More

Vanderbilt Comments on Patient Error, CMS Corrective Action Plan

Following a medication error last December that resulted in a patient death, Vanderbilt University Medical Center faced scrutiny by CMS, which could have potentially impacted Medicare reimbursement. However, on Nov. 29, the federal agency accepted a corrective action plan submitted by the city's academic medical center.

Read More

Lifepoint Health And Rcch Healthcare Partners Announce Completion Of Merger

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: